Magellan Asset Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,133
Closed -$49K 100
2020
Q2
$49K Sell
1,133
-147
-11% -$5.81K ﹤0.01% 67
2020
Q1
$42K Hold
1,280
﹤0.01% 69
2019
Q4
$47K Hold
1,280
﹤0.01% 71
2019
Q3
$43K Buy
1,280
+288
+29% +$10.2K ﹤0.01% 73
2019
Q2
$39K Sell
992
-441
-31% -$17.5K ﹤0.01% 72
2019
Q1
$58K Hold
1,433
﹤0.01% 64
2018
Q4
$46K Buy
1,433
+492
+52% +$19.9K ﹤0.01% 68
2018
Q3
$48K Hold
941
﹤0.01% 68
2018
Q2
$47K Hold
941
﹤0.01% 66
2018
Q1
$48K Buy
941
+273
+41% +$14.6K ﹤0.01% 63
2017
Q4
$35K Buy
668
+168
+34% +$8.35K ﹤0.01% 69
2017
Q3
$24K Buy
500
+200
+67% +$9.51K ﹤0.01% 79
2017
Q2
$14K Buy
+300
New +$13.8K ﹤0.01% 86

Other funds holding FMS

Magellan Asset Management's FMS Position: Q3 2020 in Review

Magellan Asset Management sold out of Fresenius Medical Care (FMS) in Q3 2020, closing a stake of 1,133 shares — an estimated $49K sold.

Magellan Asset Management first reported a position in FMS in Q2 2017 and held it in 13 quarters. The position peaked at $58K in Q1 2019. 181 funds tracked by Wall St. Rank hold FMS as of Q3 2020.

  • Magellan Asset Management reported no remaining Fresenius Medical Care position as of Q3 2020 after selling out during the quarter.
  • Magellan Asset Management sold 1,133 Fresenius Medical Care shares in Q3 2020, an estimated $49K.
  • Magellan Asset Management first reported a position in Fresenius Medical Care in Q2 2017 and held it in 13 quarters.
  • Magellan Asset Management's Fresenius Medical Care position peaked at $58K in Q1 2019.
  • 181 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2020.

Based on Magellan Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.